Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1220 | 9128 | 46.2 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
262 | 3 | AUTOPHAGY//RESVERATROL//HISTONE DEACETYLASE INHIBITOR | 44558 |
1220 | 2 | PTEN//MTOR//COWDEN SYNDROME | 9128 |
1300 | 1 | MTOR//PIK3CA//PI3K INHIBITOR | 2731 |
2908 | 1 | PTEN//COWDEN SYNDROME//LHERMITTE DUCLOS DISEASE | 2116 |
6422 | 1 | RHEB//RICTOR//REDD1 | 1485 |
6528 | 1 | PDK1//AKT//AKT2 | 1473 |
14515 | 1 | S6K2//P70 S6 KINASE//RIBOSOMAL S6 KINASE 2 S6K2 | 765 |
23185 | 1 | WIP1//PPM1D//CELL CYCLE CONTROL TUMORIGENESIS GRP | 355 |
34692 | 1 | PKN//PRK1//PKN ALPHA | 108 |
35578 | 1 | PHLPP1//PHLPP//PHLPP2 | 95 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PTEN | authKW | 964710 | 9% | 33% | 863 |
2 | MTOR | authKW | 566621 | 9% | 21% | 795 |
3 | COWDEN SYNDROME | authKW | 267900 | 1% | 70% | 115 |
4 | AKT | authKW | 246886 | 8% | 10% | 731 |
5 | LHERMITTE DUCLOS DISEASE | authKW | 217933 | 1% | 88% | 74 |
6 | PIK3CA | authKW | 209522 | 2% | 38% | 165 |
7 | PI3K | authKW | 191042 | 4% | 16% | 365 |
8 | RAPAMYCIN | authKW | 190580 | 4% | 15% | 377 |
9 | COWDEN DISEASE | authKW | 179991 | 1% | 77% | 70 |
10 | MTORC2 | authKW | 133214 | 1% | 59% | 68 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 38795 | 34% | 0% | 3146 |
2 | Cell Biology | 19058 | 24% | 0% | 2235 |
3 | Biochemistry & Molecular Biology | 10960 | 31% | 0% | 2852 |
4 | Genetics & Heredity | 1716 | 7% | 0% | 647 |
5 | Chemistry, Medicinal | 1454 | 4% | 0% | 410 |
6 | Pathology | 965 | 4% | 0% | 329 |
7 | Biophysics | 593 | 4% | 0% | 370 |
8 | Medicine, Research & Experimental | 353 | 4% | 0% | 324 |
9 | Hematology | 343 | 3% | 0% | 248 |
10 | Developmental Biology | 276 | 1% | 0% | 136 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN CANC GENET PROGRAM | 42370 | 0% | 30% | 42 |
2 | STANLEY SHALOM ZIELONY NURSING EXCELLENCE | 33413 | 0% | 50% | 20 |
3 | CELL CYCLE CONTROL TUMORIGENESIS GRP | 30090 | 0% | 100% | 9 |
4 | HUMAN CANC GENET GRP | 29552 | 0% | 27% | 33 |
5 | GRP PHOSPHOSITES | 22915 | 0% | 57% | 12 |
6 | HIGH THROUGHPUT SCREENING MOL PHARMACOL | 18199 | 0% | 78% | 7 |
7 | CHARLES A DANA HUMAN CANC GENET UNIT | 16844 | 0% | 46% | 11 |
8 | PROT PHOSPHORYLAT UNIT | 15701 | 0% | 10% | 45 |
9 | STANLEY SHALOM ZIELONY NURSING | 13929 | 0% | 83% | 5 |
10 | CANC METAB DMPK | 13373 | 0% | 100% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENE | 8382 | 2% | 1% | 217 |
2 | MOLECULAR CANCER THERAPEUTICS | 8380 | 1% | 3% | 102 |
3 | CLINICAL CANCER RESEARCH | 6697 | 2% | 1% | 176 |
4 | ONCOTARGET | 6462 | 2% | 1% | 157 |
5 | CANCER RESEARCH | 5473 | 3% | 1% | 262 |
6 | CELLULAR SIGNALLING | 5400 | 1% | 2% | 85 |
7 | JOURNAL OF BIOLOGICAL CHEMISTRY | 4702 | 5% | 0% | 496 |
8 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 4199 | 1% | 2% | 80 |
9 | CURRENT CANCER DRUG TARGETS | 3322 | 0% | 3% | 31 |
10 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2397 | 2% | 1% | 141 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PTEN | 964710 | 9% | 33% | 863 | Search PTEN | Search PTEN |
2 | MTOR | 566621 | 9% | 21% | 795 | Search MTOR | Search MTOR |
3 | COWDEN SYNDROME | 267900 | 1% | 70% | 115 | Search COWDEN+SYNDROME | Search COWDEN+SYNDROME |
4 | AKT | 246886 | 8% | 10% | 731 | Search AKT | Search AKT |
5 | LHERMITTE DUCLOS DISEASE | 217933 | 1% | 88% | 74 | Search LHERMITTE+DUCLOS+DISEASE | Search LHERMITTE+DUCLOS+DISEASE |
6 | PIK3CA | 209522 | 2% | 38% | 165 | Search PIK3CA | Search PIK3CA |
7 | PI3K | 191042 | 4% | 16% | 365 | Search PI3K | Search PI3K |
8 | RAPAMYCIN | 190580 | 4% | 15% | 377 | Search RAPAMYCIN | Search RAPAMYCIN |
9 | COWDEN DISEASE | 179991 | 1% | 77% | 70 | Search COWDEN+DISEASE | Search COWDEN+DISEASE |
10 | MTORC2 | 133214 | 1% | 59% | 68 | Search MTORC2 | Search MTORC2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LAPLANTE, M , SABATINI, DM , (2012) MTOR SIGNALING IN GROWTH CONTROL AND DISEASE.CELL. VOL. 149. ISSUE 2. P. 274-293 | 92 | 53% | 2214 |
2 | MAGNUSON, B , EKIM, B , FINGAR, DC , (2012) REGULATION AND FUNCTION OF RIBOSOMAL PROTEIN S6 KINASE (S6K) WITHIN MTOR SIGNALLING NETWORKS.BIOCHEMICAL JOURNAL. VOL. 441. ISSUE . P. 1 -21 | 164 | 73% | 254 |
3 | LIU, PX , CHENG, HL , ROBERTS, TM , ZHAO, JJ , (2009) TARGETING THE PHOSPHOINOSITIDE 3-KINASE PATHWAY IN CANCER.NATURE REVIEWS DRUG DISCOVERY. VOL. 8. ISSUE 8. P. 627 -644 | 117 | 60% | 963 |
4 | ZONCU, R , EFEYAN, A , SABATINI, DM , (2011) MTOR: FROM GROWTH SIGNAL INTEGRATION TO CANCER, DIABETES AND AGEING.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 12. ISSUE 1. P. 21 -35 | 86 | 51% | 1560 |
5 | GUERTIN, DA , SABATINI, DM , (2007) DEFINING THE ROLE OF MTOR IN CANCER.CANCER CELL. VOL. 12. ISSUE 1. P. 9 -22 | 86 | 66% | 1505 |
6 | HOLLANDER, MC , BLUMENTHAL, GM , DENNIS, PA , (2011) PTEN LOSS IN THE CONTINUUM OF COMMON CANCERS, RARE SYNDROMES AND MOUSE MODELS.NATURE REVIEWS CANCER. VOL. 11. ISSUE 4. P. 289 -301 | 118 | 62% | 308 |
7 | SALMENA, L , CARRACEDO, A , PANDOLFI, PP , (2008) TENETS OF PTEN TUMOR SUPPRESSION.CELL. VOL. 133. ISSUE 3. P. 403 -414 | 93 | 79% | 541 |
8 | HASSAN, B , AKCAKANAT, A , HOLDER, AM , MERIC-BERNSTAM, F , (2013) TARGETING THE PI3-KINASE/AKT/MTOR SIGNALING PATHWAY.SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 22. ISSUE 4. P. 641 -+ | 142 | 71% | 27 |
9 | HUANG, KZ , FINGAR, DC , (2014) GROWING KNOWLEDGE OF THE MTOR SIGNALING NETWORK.SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. VOL. 36. ISSUE . P. 79 -90 | 112 | 71% | 53 |
10 | LESLIE, NR , LONGY, M , (2016) INHERITED PTEN MUTATIONS AND THE PREDICTION OF PHENOTYPE.SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. VOL. 52. ISSUE . P. 30 -38 | 90 | 78% | 7 |
Classes with closest relation at Level 2 |
Rank | Class id | link |
---|---|---|
1 | 3108 | FOXM1//FOXO1//FOXO |
2 | 536 | X LINKED AGAMMAGLOBULINEMIA//BTK//SH2 DOMAIN |
3 | 1632 | EIF4E//TRANSLATION INITIATION//IRES |
4 | 1854 | ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX |
5 | 2357 | PEUTZ JEGHERS SYNDROME//AMPK//LKB1 |
6 | 4146 | PIM KINASE//PIM 1//PIM 2 |
7 | 1128 | AUTOPHAGY//BECLIN 1//LC3 |
8 | 2150 | HIF 1 ALPHA//HYPOXIA INDUCIBLE FACTOR//HIF 1 |
9 | 1195 | JNK//ERK5//MAP KINASE |
10 | 652 | HER2//TRASTUZUMAB//HER 2 NEU |